Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells
Abstract
The p
* Corresponding authors
a
Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
E-mail:
guanxin_shen@yahoo.com.cn
b
Department of Biomedical Engineering, The Vontz Center for Molecular Studies, College of Engineering and College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA
E-mail:
guop@purdue.edu
c Wuhan Institute of Biological Products, Wuhan, China
The p
L. Li, J. Liu, Z. Diao, D. Shu, P. Guo and G. Shen, Mol. BioSyst., 2009, 5, 1361 DOI: 10.1039/B903428E
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content